GLP1R and metabolic syndrome: The robust evidence mentioned in our review showed that losing adiposity with the help of GLP1-RA can ameliorate all the cardiometabolic risk factors, corroborating the standard therapies for hypertension, dyslipidemia and diabetes thus improving the chances to reach therapeutic goals more easily.